|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.460 CNY | -2.99% |
|
-4.48% | -13.66% |
| Market Cap | 3.81B 563M 494M 460M 422M 792M 54.18B 805M 5.46B 2.13B 26.64B 2.11B 2.07B 92.1B | P/E 2024 |
65.6x | P/E 2025 | 89.6x |
|---|---|---|---|---|---|
| Enterprise Value | 3.33B 492M 432M 402M 369M 693M 47.37B 703M 4.77B 1.86B 23.29B 1.85B 1.81B 80.52B | EV / Sales 2024 |
3.66x | EV / Sales 2025 | 4.3x |
| Free-Float |
34.06% | Yield 2024 |
0.16% | Yield 2025 | 0.23% |
| 1 day | -2.99% | ||
| 1 week | -4.48% | ||
| Current month | +9.54% | ||
| 1 month | +1.50% | ||
| 3 months | -7.79% | ||
| 6 months | -17.48% | ||
| Current year | -13.66% |
| 1 week | 7.41 | 7.91 | |
| 1 month | 6.63 | 8.07 | |
| Current year | 6.63 | 11.02 | |
| 1 year | 6.63 | 11.85 | |
| 3 years | 5.84 | 11.85 | |
| 5 years | 5.84 | 15.17 | |
| 10 years | 5.84 | 15.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ai Guo Shi
CEO | Chief Executive Officer | 62 | 2022-04-05 |
Jin feng Yue
DFI | Director of Finance/CFO | - | 2022-12-01 |
Li Jun Wu
PRN | Corporate Officer/Principal | 52 | 2018-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Wen Bo Su
CHM | Chairman | 60 | 2014-05-07 |
Ai Guo Shi
CHM | Chairman | 62 | 2017-06-29 |
Zhi Jun Liu
BRD | Director/Board Member | 54 | 2016-04-11 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -2.99% | -4.48% | -16.27% | -34.45% | 580M | ||
| -1.35% | -0.82% | -10.59% | -4.17% | 13.62B | ||
| -2.94% | -3.76% | -31.42% | -51.83% | 5.23B | ||
| -0.78% | +1.50% | -1.38% | -2.62% | 4.83B | ||
| -3.19% | -0.61% | +1.11% | -32.57% | 4.18B | ||
| -2.43% | -3.43% | +0.94% | -10.97% | 3.71B | ||
| -1.33% | +1.56% | -2.63% | -4.79% | 3.68B | ||
| -1.19% | +2.47% | -3.08% | +10.29% | 3.52B | ||
| -2.28% | -0.77% | -14.27% | -23.60% | 2.46B | ||
| -3.10% | -2.19% | -5.97% | +39.02% | 1.88B | ||
| Average | -2.16% | -3.15% | -8.35% | -11.57% | 4.37B | |
| Weighted average by Cap. | -1.88% | -2.86% | -8.77% | -11.52% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 980M 145M 127M 118M 109M 204M 13.94B 207M 1.4B 549M 6.85B 543M 532M 23.7B | 916M 135M 119M 110M 101M 190M 13.02B 193M 1.31B 512M 6.4B 508M 497M 22.13B |
| Net income | 60.07M 8.87M 7.79M 7.25M 6.65M 12.49M 854M 12.69M 86.05M 33.62M 420M 33.3M 32.59M 1.45B | 49.21M 7.27M 6.38M 5.94M 5.45M 10.23M 700M 10.39M 70.49M 27.54M 344M 27.28M 26.69M 1.19B |
| Net Debt | -357M -52.74M -46.32M -43.08M -39.53M -74.27M -5.08B -75.42M -512M -200M -2.5B -198M -194M -8.63B | -479M -70.74M -62.13M -57.78M -53.02M -99.63M -6.81B -101M -686M -268M -3.35B -266M -260M -11.58B |
Employees
1,332
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | CN¥7.460 | -2.99% | 3,948,200 |
| 26-07-23 | CN¥7.690 | +1.45% | 4,606,000 |
| 26-07-22 | CN¥7.580 | -0.92% | 6,119,301 |
| 26-07-21 | CN¥7.650 | -1.16% | 7,723,950 |
| 26-07-20 | CN¥7.740 | -0.90% | 8,726,500 |
- Stock Market
- Stocks
- 002644 Stock
Select your edition
All financial news and data tailored to specific country editions
















